BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 15744453)

  • 1. Hydroxymethylglutaryl-coenzyme A reductase inhibitors and osteoporosis: a meta-analysis.
    Hatzigeorgiou C; Jackson JL
    Osteoporos Int; 2005 Aug; 16(8):990-8. PubMed ID: 15744453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of statins for osteoporosis: a systematic review and meta-analysis.
    An T; Hao J; Sun S; Li R; Yang M; Cheng G; Zou M
    Osteoporos Int; 2017 Jan; 28(1):47-57. PubMed ID: 27888285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HMG-CoA reductase inhibitors (statins) and bone mineral density: a meta-analysis.
    Liu J; Zhu LP; Yang XL; Huang HL; Ye DQ
    Bone; 2013 May; 54(1):151-6. PubMed ID: 23388418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of statins and fracture: results of 4 prospective studies and cumulative meta-analysis of observational studies and controlled trials.
    Bauer DC; Mundy GR; Jamal SA; Black DM; Cauley JA; Ensrud KE; van der Klift M; Pols HA
    Arch Intern Med; 2004 Jan; 164(2):146-52. PubMed ID: 14744837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydroxymethylglutaryl-coenzyme A reductase inhibitors in osteoporosis management.
    Coons JC
    Ann Pharmacother; 2002 Feb; 36(2):326-30. PubMed ID: 11847956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statin use, clinical fracture, and bone density in postmenopausal women: results from the Women's Health Initiative Observational Study.
    LaCroix AZ; Cauley JA; Pettinger M; Hsia J; Bauer DC; McGowan J; Chen Z; Lewis CE; McNeeley SG; Passaro MD; Jackson RD
    Ann Intern Med; 2003 Jul; 139(2):97-104. PubMed ID: 12859159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Statins on Bone Mineral Density and Fracture Risk: A PRISMA-compliant Systematic Review and Meta-Analysis.
    Wang Z; Li Y; Zhou F; Piao Z; Hao J
    Medicine (Baltimore); 2016 May; 95(22):e3042. PubMed ID: 27258488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statins and bone health in postmenopausal women: a systematic review of randomized controlled trials.
    Yue J; Zhang X; Dong B; Yang M
    Menopause; 2010; 17(5):1071-9. PubMed ID: 20473231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of statins on bone mineral density: a meta-analysis of clinical studies.
    Uzzan B; Cohen R; Nicolas P; Cucherat M; Perret GY
    Bone; 2007 Jun; 40(6):1581-7. PubMed ID: 17409043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitors of hydroxymethylglutaryl-coenzyme A reductase and risk of fracture among older women.
    Chan KA; Andrade SE; Boles M; Buist DS; Chase GA; Donahue JG; Goodman MJ; Gurwitz JH; LaCroix AZ; Platt R
    Lancet; 2000 Jun; 355(9222):2185-8. PubMed ID: 10881890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HMG-CoA reductase inhibitors in osteoporosis: do they reduce the risk of fracture?
    Schlienger RG; Meier CR
    Drugs Aging; 2003; 20(5):321-36. PubMed ID: 12696993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skeletal effects of statins.
    Yaturu S
    Endocr Pract; 2003; 9(4):315-20. PubMed ID: 14561578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin D analogs versus native vitamin D in preventing bone loss and osteoporosis-related fractures: a comparative meta-analysis.
    Richy F; Schacht E; Bruyere O; Ethgen O; Gourlay M; Reginster JY
    Calcif Tissue Int; 2005 Mar; 76(3):176-86. PubMed ID: 15692726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Milk and Dairy Products on the Prevention of Osteoporosis and Osteoporotic Fractures in Europeans and Non-Hispanic Whites from North America: A Systematic Review and Updated Meta-Analysis.
    Matía-Martín P; Torrego-Ellacuría M; Larrad-Sainz A; Fernández-Pérez C; Cuesta-Triana F; Rubio-Herrera MÁ
    Adv Nutr; 2019 May; 10(suppl_2):S120-S143. PubMed ID: 31089740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Statins on Relative Risk of Fractures for Older Adults: An Updated Systematic Review With Meta-Analysis.
    Shi R; Mei Z; Zhang Z; Zhu Z
    J Am Med Dir Assoc; 2019 Dec; 20(12):1566-1578.e3. PubMed ID: 31395495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statin use, bone mineral density, and fracture risk: Geelong Osteoporosis Study.
    Pasco JA; Kotowicz MA; Henry MJ; Sanders KM; Nicholson GC;
    Arch Intern Med; 2002 Mar; 162(5):537-40. PubMed ID: 11871921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statins and osteoporosis: a clinical review.
    Gonyeau MJ
    Pharmacotherapy; 2005 Feb; 25(2):228-43. PubMed ID: 15767237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statins and bone metabolism.
    Horiuchi N; Maeda T
    Oral Dis; 2006 Mar; 12(2):85-101. PubMed ID: 16476028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The degree of osteoporosis in patients with vertebral fracture and patients with hip fracture: relationship to incidence of vertebral fracture.
    Takahashi M; Kushida K; Naitou K
    J Bone Miner Metab; 1999; 17(3):187-94. PubMed ID: 10757678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HMG CoA reductase inhibitors and the skeleton: a comprehensive review.
    Bauer DC
    Osteoporos Int; 2003 Jun; 14(4):273-82. PubMed ID: 12736772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.